Novacyt S.A. (ALNOV.PA)
EUR 0.45
(-2.68%)
EUR 0.45
(-2.68%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -29.51 Million GBP | -77.79% |
| 2022 | -16.6 Million GBP | -1114.48% |
| 2021 | -1.36 Million GBP | -100.82% |
| 2020 | 167.44 Million GBP | 14780.93% |
| 2019 | -1.14 Million EUR | 8.65% |
| 2018 | -1.24 Million EUR | 65.45% |
| 2017 | -3.61 Million EUR | 4.96% |
| 2016 | -3.8 Million EUR | 60.92% |
| 2015 | -9.73 Million EUR | -556.87% |
| 2014 | -1.48 Million EUR | -37.9% |
| 2013 | -1.07 Million EUR | -129.3% |
| 2012 | -468.46 Thousand EUR | 18.15% |
| 2011 | -572.31 Thousand EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 FY | -29.51 Million GBP | -77.79% |
| 2023 Q1 | -3.72 Million GBP | 11.83% |
| 2023 Q2 | -3.8 Million GBP | -2.33% |
| 2023 Q4 | -13.1 Million EUR | 0.0% |
| 2022 Q4 | -4.22 Million GBP | 0.93% |
| 2022 FY | -16.6 Million GBP | -1114.48% |
| 2022 Q2 | -9.91 Million GBP | 0.0% |
| 2022 Q3 | -4.26 Million GBP | 57.03% |
| 2021 Q2 | 25.38 Million EUR | 0.0% |
| 2021 FY | -1.36 Million GBP | -100.82% |
| 2021 Q4 | 14.97 Million EUR | 0.0% |
| 2020 FY | 167.44 Million GBP | 14780.93% |
| 2020 Q2 | 48.67 Million EUR | 0.0% |
| 2019 FY | -1.14 Million EUR | 8.65% |
| 2019 Q2 | -605 Thousand EUR | 0.0% |
| 2019 Q4 | -640 Thousand EUR | 0.0% |
| 2018 FY | -1.24 Million EUR | 65.45% |
| 2018 Q4 | 928 Thousand EUR | 0.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2017 Q4 | - EUR | 0.0% |
| 2017 FY | -3.61 Million EUR | 4.96% |
| 2016 Q4 | - EUR | 0.0% |
| 2016 FY | -3.8 Million EUR | 60.92% |
| 2015 Q2 | - EUR | 0.0% |
| 2015 FY | -9.73 Million EUR | -556.87% |
| 2014 FY | -1.48 Million EUR | -37.9% |
| 2014 Q2 | - EUR | 0.0% |
| 2013 FY | -1.07 Million EUR | -129.3% |
| 2012 FY | -468.46 Thousand EUR | 18.15% |
| 2011 FY | -572.31 Thousand EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Affluent Medical SA | -13.06 Million EUR | -125.899% |
| Bluelinea Société Anonyme | -1.61 Million EUR | -1730.263% |
| Carmat SA | -52.51 Million EUR | 43.799% |
| Diagnostic Medical Systems S.A. | -2.26 Million EUR | -1203.135% |
| Euromedis Groupe | -5.55 Million EUR | -431.132% |
| Eurobio Scientific Société anonyme | 10.14 Million EUR | 391.056% |
| Ikonisys S.A. | -2.19 Million EUR | -1245.472% |
| Implanet S.A. | -6.15 Million EUR | -379.234% |
| Median Technologies SA | -23 Million EUR | -28.297% |
| SpineGuard SA | -3.97 Million EUR | -642.336% |
| Theraclion SA | -3.15 Million EUR | -835.828% |
| Euroapi S.A. | -234.3 Million EUR | 87.402% |
| Guerbet SA | 38.67 Million EUR | 176.326% |